Ho Chaw Sing

Dr Ho Chaw Sing

Co-founder and Chief Executive Officer,

National Additive Manufacturing Innovation Cluster (NAMIC);

Adjunct Professor,

Department of Electrical and Computer Engineering,

Department of Mechanical Engineering,

College of Design and Engineering,

National University of Singapore

Dr Ho is the CEO of NAMIC, a national accelerator he co-founded that focusses on translational research to catalyse and scale industrial adoption of digital hybrid additive manufacturing technologies. In this role, he oversees Singapore’s development and implementation of additive manufacturing (AM) Research Innovation and Enterprise (RIE) strategies.

Active in the global AM deep tech scene, Dr Ho is involved in international forums and organisations across several industry sectors, focussed on technology commercialisation that will grow and transform enterprises in Singapore. He is the Chair’s Advisory Group Co-Convenor in ISO/TC 261 and co-chairs the AM Standards Technical Committee under Singapore Standards Council. He is an advisor to startups and serves in thematic scientific and technology panels for organisations including the Campus for Research Excellence and Technological Enterprise under the National Research Foundation Singapore, Norway’s SINTEF, and Singapore Maritime Institute, among others.

Before joining the public sector, Dr Ho spent 16 years at HP and Globalfoundries. Dr Ho is an ASTM International board member and serves as an Adjunct Professor at NUS College of Design and Engineering. He holds several U.S. and internationally issued patents. An INSEAD alumnus, Dr Ho earned his doctorate and undergraduate degrees in Electrical and Computer Engineering from NUS.

Presentation Synopsis
Keynote Lecture - Enhancing Patient Outcomes with Precision Medicine Through the Convergence of AI and AM Technology
This talk explores how technology, specifically AI and advanced manufacturing is transforming healthcare by enabling personalised, efficient, and scalable solutions. Together, they are addressing long-standing gaps in patient care, particularly in areas where traditional methods fall short.

The talk will cover how AI and AM accelerate product development to realise novel and bio-compatible solutions in wearables and implantables. The advent of Point-of-Care service and manufacturing translates real-time diagnostics to personalised treatment planning, and allow clinicians to adopt patient-specific solutions to increase the success rate of complex treatments such as surgeries. The synergy between AI and additive manufacturing is unlocking new frontiers in clinical innovation. By enabling hyper-personalisation, reducing costs, and improving accessibility, this convergence is poised to meet critical unmet patient needs and redefine the future of healthcare delivery.

< Back to Speakers' Information